GETTING MY SAH TO WORK

In August 2022 enrollment started over a research assessing the influence of semaglutide on tau accumulation in the brains of people who find themselves amyloid-positive, with or without having diabetes, and with no or mild cognitive impairment (Koychev et al., 2024). The research on the University of Oxford in the U.K. will deal with 88 members wi